Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with Hig... (study patients received doses of Campath...)

HOME >> MEDICINE >> TECHNOLOGY

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

Date:12/9/2008

study, patients received doses of Campath three times per week. After a median follow-up time of 37.9 months, the study found an ORR of 34 percent, a CRR of four percent, and a PRR of 30 percent among the total patient population. Median PFS time was 7.7 months, and median OS time was 19.1 months.

"These analyses are an important step forward in the consideration of targeted therapies for treating high-risk CLL," said Pam Cyrus, vice president, Medical Affairs, Oncology, Bayer HealthCare Pharmaceuticals. "We remain committed to determining the best treatment regimen for all patients with CLL, including this high-risk patient population."

CLL is characterized by the accumulation of functionally immature white blood cells (lymphocytes) in the bone marrow, blood, lymph tissue and other organs. Roughly 90,000 people in the United States are living with CLL, according to the Leukemia and Lymphoma Society. More people are living with CLL than any other type of leukemia, and most people with CLL are at least 50 years old.

About the Studies

Abstract #3164

Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories

Using the largest database of efficacy analysis of Campath in CLL, researchers identified 138 CLL patients (73 male, 65 female, with a median age of 64 years) stratified according to cytogenetic markers that were identified by fluorescent in situ hybridization (FISH) testing. The median number of two prior therapies in this group was two (range, 0 - 10), and of the patients who received prior treatment with fludarabine (n=113), 70 percent were refractory to the fludarabine treatment, 25 percent sensitive, and in five percent this was unknown. Responses were evaluated according to the National Cancer Institute (NCI) criteria, and researchers also asse
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial

Post Your Comments:

(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...

(Date:12/15/2009)... today,s regular meeting of the board of directors of ... board declared a regular quarterly dividend of 31 cents ... record at the close of business on February 10, ... The Lubrizol Corporation (NYSE: LZ ) is ... technologies that improve the quality and performance of our ...

(Date:12/15/2009)... University Hospital in Belgium, among the first hospitals ... arc therapy, has carried out its first treatment ... Varian Medical Systems ( VAR). A 56-year-old male ... seconds, over four times faster than possible using ... taken more than five minutes using conventional intensity-modulated ...

[0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard [0] Lubrizol Declares Dividend [0] European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient

... Regenerating Damaged Cardiac Tissue Is Significant for the ... 21 Florida Atlantic,University received U.S. patent no. ... which induces and restores cardiac,muscle function. The invention ... research, Dr. Larry F. Lemanski and his postdoctoral ...

... Treatment with Norditropin increases gain in height for girls with Turner ... ... PRINCETON, N.J., Sept. 21 Novo Nordisk today,announced that Norditropin(R) (somatropin ... (FDA) for the treatment,of children with short stature associated with Turner ...

Other Medicine Technology:FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 2 FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 3 FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 4 Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 2 Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 3 Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 4 Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 5 Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 6

FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome

(Date:12/15/2009)... Continuing Strike Force Operations Lead to Indictment of ... with more than $61 Million in Fraudulent Billing ... Thirty people have been charged in ... to submit more than $61 million in false ... of the Medicare Fraud Strike Force, Department of ...

(Date:12/15/2009)... call for help, experts say , , TUESDAY, Dec. 15 ... teaching children how to spot the signs of stroke ... study shows. , Emergency medical treatment within three hours ... of brain damage and lead to better recovery. , ... 515 sixth graders in Texas who were divided into ...

(Date:12/15/2009)... doctors decide benefits of imaging outweigh the risks , , ... pose a serious risk to people with heart pacemakers, ... exposed pacemakers to a simulated MRI magnetic field and ... of the pacemaker lead, where it would touch the ... MRI magnetic pulses caused certain pacemakers to deliver a ...

(Date:12/15/2009)... -- Virtual Health Technologies, Inc. (OTC Bulletin Board: ... owned operating subsidiary of VHGI) has appointed two ... to assist with bringing the Treasure Gulch and ... as possible. Additionally, the company is informing interested ... schedule a Live Investor Town Hall Meeting so ...

(Date:12/15/2009)... Aon Consulting, the global human ... AON ), today announced Lisa ... vice president with the Health & Benefits ... Practice. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO ... will work under the direction of Aon ...

Breaking Medicine News(10 mins):Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5 Health News:Boosting Kids' Stroke IQ May Save Lives 2 Health News:Patients With Pacemakers Should Avoid MRI Scans 2 Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 2 Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 3 Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 4 Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 5 Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 2 Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 3 Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 4

[0] Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La.[0] Boosting Kids' Stroke IQ May Save Lives [0] Patients With Pacemakers Should Avoid MRI Scans [0] VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice

... April 17 Young Innovations,Inc. (Nasdaq: YDNT ) ... results with a live and on-demand web cast conference ... Time. A live audio,broadcast of the call will be ... live audio broadcast,will also be available through the Company,s ...

... long hours, night shifts or job insecurity, study says , , ... as conflicts with bosses or co-workers are more likely than ... sleep. , That,s the conclusion of a study by University ... about 2,300 U.S. adults who were followed for up to ...

... in patients , , THURSDAY, April 17 (HealthDay News) -- ... Alzheimer,s drug reinforces the notion that the compound is ... to moderate Alzheimer,s patients. , A second analysis of ... reveals that by improving the Alzheimer,s patients, ability to ...

... A childs innocence and vulnerability presents a target ... researchers are beginning to understand the communication process by ... This information could better equip parents and community members ... child sexual abuse. , Our children are our greatest ...

... Typing on a keyboard or scribbling on paper may be ... the body moves, according to new motor development research. , ... that lead to words, and we use grammar to put ... of health and kinesiology. "One of the fundamental questions in ...

... 17 The Juvenile,Products Manufacturers Association (JPMA), which ... United States, stands by the,scientific research indicating that ... scientific evaluation process of the National,Toxicology Program,s (NTP) ... Following an expert panel review last year, this ...

Other Medicine News:Health News:Young Innovations, Inc. Provides First Quarter Conference Call Details 2 Health News:Work Conflicts Can Do a Job on Your Sleep 2 Health News:Experimental Alzheimer's Drug Shows Promise 2 Health News:Experimental Alzheimer's Drug Shows Promise 3 Health News:MU researchers reveal communication tactics used by sexual predators to entrap children 2 Health News:New research shows slight of hand is not so slight 2 Health News:Juvenile Products Manufacturers Association Supports Safety of Baby Bottles 2

Young Innovations, Inc. Provides First Quarter Conference Call Details Work Conflicts Can Do a Job on Your Sleep Experimental Alzheimer's Drug Shows Promise MU researchers reveal communication tactics used by sexual predators to entrap children New research shows slight of hand is not so slight Juvenile Products Manufacturers Association Supports Safety of Baby Bottles

The clarity and performance of glass with shatterproof safety of plastic....

Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....

... technology uses advanced spectral analysis techniques ... images and provide detailed information on ... plaques. The colorized VH images show ... dense calcium, and necrotic core. VH ...

... Medtronic is changing the way clinicians and ... Medtronic CareLink Monitor and a standard phone ... from their home or while traveling. 1 ... the ability to review device data when ...

Medicine Products:

Fisherbrand Plastic Microhematocrit Tubes Hemato-Clad Mylar® Wrapped Hematocrit Tubes VH™ IVUS Imaging System CareLink® Network

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with Hig...(study patients received doses of Campath...),Health